Antiviral Drugs

Anti‐Monkeypox Infection Approaches: From Prevention to Therapeutic Lines

“…As a result, renal function (serum creatinine and urine protein) must be monitored 48 h before each dose of cidofovir, and dose adjustments must be made if renal function changes 20,58‐60 . In general, brincidofovir, a prodrug of cidofovir, has a better safety profile than cidofovir, with no reports of serious renal toxicity or other adverse events in the treatment of CMV and Mpox infection when compared to cidofovir 61,62 …”

“…20,[58][59][60] In general, brincidofovir, a prodrug of cidofovir, has a better safety profile than cidofovir, with no reports of serious renal toxicity or other adverse events in the treatment of CMV and Mpox infection when compared to cidofovir. 61,62…”